Refractory marginal zone lymphoma uncovers activated phosphoinositide 3-kinase delta syndrome type 1 (APDS1).
Saved in:
| Title: | Refractory marginal zone lymphoma uncovers activated phosphoinositide 3-kinase delta syndrome type 1 (APDS1). |
|---|---|
| Authors: | Wonnaparhown A; Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic, Phoenix, Ariz., Farley M; Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic, Phoenix, Ariz., Miller H; Center for Cancer and Blood Disorders, Phoenix Children's/Mayo Clinic Arizona, Phoenix, Ariz., Cunningham-Rundles C; Division of Allergy and Clinical Immunology, Department of Medicine and Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY., Freeman C; Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic, Phoenix, Ariz., Squire J; Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic, Jacksonville, Fla., Hilal T; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, Ariz., Rosenthal A; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, Ariz. |
| Source: | The journal of allergy and clinical immunology. Global [J Allergy Clin Immunol Glob] 2025 May 26; Vol. 4 (3), pp. 100503. Date of Electronic Publication: 2025 May 26 (Print Publication: 2025). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918453488706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-8293 (Electronic) Linking ISSN: 27728293 NLM ISO Abbreviation: J Allergy Clin Immunol Glob Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2772-8293 |
|---|---|
| DOI: | 10.1016/j.jacig.2025.100503 |
